Home > News > Opinion: Stars aligning for nano offerings
October 28th, 2005
Opinion: Stars aligning for nano offerings
Abstract:
Dumas Garrett: Nanotechnology faces many obstacles dampening its market viability – namely funding constraints precipitated by Wall Street's wariness of technology. The vast majority of nanotech companies worldwide are small startups or university-led initiatives. Only 10 percent of these companies have ever attracted venture capital, according to our research, and just 10 percent of those have received more than one round of financing.
Source:
smalltimes
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||